oral insulin articles & resources on Made-in-China.com

ORMP Would Purchase an Aggregate of 1,580,000 Shares

Dec 30, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced that it has entered into definitive agreements with investors to purchase an aggregate of 1,580,000 shares of common stock at a price ...

Tags: Oramed Pharmaceuticals, Aegis Capital, registered direct offering

US FDA Has Cleared Oramed's Investigational New Drug Application for ORMD-0801

May 22, 2013

The US Food and Drug Administration (FDA) has cleared Oramed's investigational new drug (IND) application for ORMD-0801, an oral insulin capsule, allowing the company to begin clinical trials of the drug. ORMD-0801 is an orally ingestible ...

Tags: FDA, Oral Insulin Capsule

Phase III Trial Results of Oral Insulin Generex Oral-Lyn to Indian Government for Approval

Jan 25, 2013

Canada’s Generex Biotechnology, through its Indian licensee Shreya Life Sciences, has submitted a dossier of recently concluded Phase III trial results of its oral insulin ‘Generex Oral-lyn’ to the Indian government for ...

Tags: Generex Biotechnology, Shreya Life Sciences, oral insulin

Oramed Has Received Approximately $540,000 Government Grant in Israel

May 10, 2012

Oramed, a wholly owned Israeli subsidiary of Oramed Pharmaceuticals, has received government grant of NIS2m (approximately $540,000) in Israel. The funds will be used to support R&D and clinical studies on the company's oral insulin ...

Tags: Oramed Pharmaceuticals, Medicine

oral insulin

ORMP Would Purchase an Aggregate of 1,580,000 Shares

US FDA Has Cleared Oramed's Investigational New Drug Application for ORMD-0801

Phase III Trial Results of Oral Insulin Generex Oral-Lyn to Indian Government for Approval

Oramed Has Received Approximately $540,000 Government Grant in Israel

Related Products